论文部分内容阅读
Hyperglycemia in Thyrotropin-releasing hormone (TRH) null mice indicates that TRH is involved in the regulation of glucose homeostasis.Further,TRH levels in the pancreas peak during the stages of late embryonic and early neonatal β cell development.These observations are consistent in linking TRH to islet cell proliferation and differentiation.We examined the effect of TRH administration in damaged pancreatic rat (streptozotocin,STZ) to determine whether TRH could improve damaged pancreatic β cells function.We hypothesize that TRH is able to reverse STZ induced hyperglycemia by increasing pancreatic islet insulin content,preventing apoptosis,and potentially induce islet regeneration.It was found that following intra-peritoneal (ip) injection,TRH (10 ug/kg body weight (bwt) reverses STZ (65 mg/kg bwt) induced hyperglycemia (TRH given 3 days after STZ injection).Increased circulating insulin levels and insulin content in extracted pancreas suggests that TRH reversed STZ induced hyperglycemia through improving pancreatic islet β cell function.Further studies show a significantly lower level of apoptosis in islets treated with TRH as well as the presence of proliferation marker nestin and Brdu,suggesting that the TRH has the potential to prevent apoptosis and stimulate islet proliferation.The mechanism study unveils that TRH receptor activation has cross-talk to EGF receptor,which may link to the capability of TRH regulation of β cell regeneration.The activity of TRH in pancreas may also influence stem cell niche in pancreas.